45760dkk
0,2 %
Date:2025-07-10Time:17:20:00Latest report:Q4-2023List:Large CapTicker:NSIS B
Market Cap:214 294 mdkkEnterprise Value:220 959 mdkkNet Sales:17 899 mdkkEarnings:3 024 mdkkEmployees:0ISIN:DK0060336014
Ratios
10-year key figure history for Novonesis turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for Novonesis with index and moving average MA50 and MA200.
Stockprice:457,60
MA50:456,58
MA200:429,15
Price/MA200:6,6 %
RSI (14):49,0
Price/MA50:0,2 %
Description
Novonesis is a biochemistry company. The company develops enzymes and various microorganisms for industrial use. The enzymes are a protein used in a number of different industries, mainly in the agricultural and food industries. Novonesis products are used in various foods and clothing and the company holds sales on a global level. Novonesis was founded in 1921 and is headquartered in Bagsværd, Denmark.
Chemicals
1 week
1 month
XP Chemistries
1,8 %
38,2 %
aXichem
1,4 %
19,5 %
Elkem
0,6 %
14,6 %
SP Group
7,8 %
11,3 %
Roblon
4,9 %
11,2 %
BEWi
2,4 %
9,4 %
Nexam Chemical
-1,0 %
8,0 %
Hexpol
2,6 %
6,8 %
Borregaard
1,0 %
6,6 %